Neuland Laboratories shares jump over 10% to record high after Q1FY27 results
The stock touched a fresh peak of ₹21,999 on the NSE, up 10.2% from its previous close of ₹19,956
Neuland Laboratories shares surged over 10% to a new record high on the NSE on Thursday, following the company's Q1FY27 results and announcement of a manufacturing capacity expansion. The stock reached a peak of ₹21,999, up 10.2% from its previous close of ₹19,956. The increase was driven by a significant improvement in profitability on a year-over-year basis, with Neuland Laboratories reporting a standalone profit after tax (PAT) of ₹147.36 crore.
This was higher than the ₹13.71 crore reported in Q1FY26 but lower than the ₹212.52 crore in the same quarter last year. The company's board approved an expansion of manufacturing capacity at its Unit 1 facility in Telangana, with the proposed addition of 18 kiloliters, requiring an investment of ₹39.8 crore. Neuland Laboratories' CEO and Managing Director, Saharsh Davuluri, stated that Q1 FY27 was broadly in line with expectations, with strong performance from both the CMS and GDS businesses, signaling a positive start to the year.
He also mentioned that customer discussions have become more in-depth, focusing on broader capability-led conversations rather than individual projects alone.
Written by urgent.news from Hindu BusinessLine's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
